HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Masaomi Ikeda Selected Research

Masaomi Ikeda Research Topics

Disease

16Neoplasms (Cancer)
09/2023 - 06/2008
16Carcinoma (Carcinomatosis)
06/2023 - 06/2008
15Urinary Bladder Neoplasms (Bladder Cancer)
09/2023 - 01/2011
7Neoplasm Metastasis (Metastasis)
02/2024 - 08/2015
6Prostatic Neoplasms (Prostate Cancer)
02/2024 - 01/2012
4Dental Caries (Decay, Dental)
05/2024 - 01/2013
4Non-Muscle Invasive Bladder Neoplasms
01/2023 - 03/2013
4Renal Cell Carcinoma (Grawitz Tumor)
01/2017 - 01/2011
2Dentin Sensitivity
01/2023 - 02/2013
2Erythema Multiforme
01/2013 - 09/2012
1Root Caries
05/2024
1Disease Progression
02/2024
1Peptic Esophagitis (Reflux Esophagitis)
01/2023
1Deglutition Disorders (Dysphagia)
01/2023
1Carcinoma in Situ
01/2023
1Non-Erosive Reflux Disease
01/2023
1Circulating Neoplastic Cells
08/2022
1Dementia (Dementias)
12/2021
1Cystitis
04/2020
1Urologic Neoplasms (Urological Cancer)
11/2019
1Margins of Excision
03/2019
1Colorectal Neoplasms (Colorectal Cancer)
03/2019
1Chronic Renal Insufficiency
02/2018
1Myxoid Liposarcoma
01/2016
1Necrosis
06/2014
1Bites and Stings (Sting)
09/2013
1Hydronephrosis
05/2013
1Stevens-Johnson Syndrome (Lyell's Syndrome)
01/2013

Drug/Important Bio-Agent (IBA)

4Proteins (Proteins, Gene)FDA Link
09/2023 - 05/2013
4Cisplatin (Platino)FDA LinkGeneric
10/2022 - 01/2011
4GemcitabineFDA Link
10/2022 - 10/2011
3Biomarkers (Surrogate Marker)IBA
05/2022 - 01/2014
3AndrogensIBA
11/2017 - 05/2014
3Doxorubicin (Adriamycin)FDA LinkGeneric
01/2014 - 01/2011
3Methotrexate (Mexate)FDA LinkGeneric
01/2014 - 01/2011
3Vinblastine (Vinblastine Sulfate)FDA Link
01/2014 - 01/2011
2FluoridesIBA
05/2024 - 01/2013
2Paclitaxel (Taxol)FDA LinkGeneric
10/2022 - 10/2011
2Prostate-Specific Antigen (Semenogelase)IBA
03/2019 - 04/2016
2C-Reactive ProteinIBA
09/2017 - 01/2017
2AlbuminsIBA
01/2017 - 06/2014
2Uroplakin IIIIBA
01/2015 - 05/2013
2Sorafenib (BAY 43-9006)FDA Link
01/2013 - 09/2012
1safrole oxide (SAFO)IBA
05/2024
1silver diammineIBA
05/2024
1Glass Ionomer CementsIBA
05/2024
1MineralsIBA
05/2024
1SilverIBA
05/2024
1Epidermal Growth Factor (EGF)IBA
09/2023
1Calcium-Binding ProteinsIBA
09/2023
1Dental MaterialsIBA
01/2023
1TheobromineIBA
01/2023
1Proton Pump InhibitorsIBA
01/2023
11- (5- (2- fluorophenyl)- 1- (pyridin- 3- ylsulfonyl)- 1H- pyrrol- 3- yl)- N- methylmethanamineIBA
01/2023
1Immune Checkpoint InhibitorsIBA
10/2022
1MicroRNAs (MicroRNA)IBA
08/2022
1Cell-Free Nucleic AcidsIBA
08/2022
1Protein Deglycase DJ-1IBA
05/2022
1iridium oxideIBA
12/2021
1IridiumIBA
12/2021
1epiplakinIBA
10/2021
1Anti-Bacterial Agents (Antibiotics)IBA
04/2020
1Cefaclor (Ceclor)FDA LinkGeneric
04/2020
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2019
1L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
01/2017
1Alkaline PhosphataseIBA
01/2017
1Hemoglobins (Hemoglobin)IBA
01/2017
1Docetaxel (Taxotere)FDA Link
01/2016
1nedaplatinIBA
01/2015
1UroplakinsIBA
01/2015
1Biological FactorsIBA
06/2014
1Cadherins (E-Cadherin)IBA
05/2013
1Coxsackie and Adenovirus Receptor-Like Membrane ProteinIBA
05/2013
1DiureticsIBA
05/2013
1Epirubicin (Ellence)FDA LinkGeneric
03/2013
1calcium phosphateIBA
02/2013

Therapy/Procedure

14Cystectomy
09/2023 - 09/2008
10Therapeutics
02/2024 - 03/2013
10Nephroureterectomy
06/2023 - 12/2013
9Drug Therapy (Chemotherapy)
10/2022 - 06/2008
5Radiotherapy
11/2017 - 01/2011
3Neoadjuvant Therapy
06/2023 - 02/2018
3Intravesical Administration
01/2023 - 03/2013
3Adjuvant Chemotherapy
11/2019 - 10/2015
3Brachytherapy
11/2017 - 05/2014
2Salvage Therapy
05/2022 - 01/2015
2Prostatectomy (Retropubic Prostatectomy)
03/2019 - 02/2006
2Nephrectomy
08/2015 - 06/2008
1Aftercare (After-Treatment)
05/2024
1Castration
02/2024
1Tooth Remineralization
01/2023
1Transurethral Resection of Bladder
01/2023
1Operative Time
01/2023
1Long-Term Care
12/2021
1Ostomy
03/2019
1Lymph Node Excision (Lymph Node Dissection)
10/2017
1Metastasectomy
09/2017
1Combination Drug Therapy (Combination Chemotherapy)
01/2016
1Chemoradiotherapy
01/2014
1Crowns (Crown, Dental)
09/2013